Biocon This fall Outcomes: Internet revenue slumps 57% YoY to Rs 135 crore
Income from operations elevated 16% year-on-year (YoY) to Rs 2,947 crore within the January-March 2024 interval.
The corporate’s board has advisable a closing dividend of Rs 0.5 per share of face worth of Rs 5 every for the monetary 12 months ended March 2024. The corporate has fastened July 5 because the document date for figuring out entitlement of members to the ultimate dividend. The dividend will likely be paid on or earlier than September 6.
EBITDA for the fourth quarter stood at Rs 916 crore, whereas margins stood at 23.4%.
The corporate’s Board has additionally permitted the re-appointment of Kiran Mazumdar Shaw as an Government Director of the corporate for an additional interval of 5 years beginning April 2025.The Board has additionally permitted the re-appointment of Siddharth Mittal because the MD for five years efficient December 2024. Mittal was first elevated to the place of CEO and MD in 2019.For FY24, the corporate’s revenue after tax greater than doubled to Rs 1,022 crore, in contrast with Rs 463 crore within the earlier fiscal. Income from operations rose 38% YoY in the identical interval 10,588 crore.On Thursday, Biocon shares closed almost 1% decrease at Rs 309 on NSE.